LLC0424
Product Specifications
Target
NSD
Applications
Epigenetics
Additionnal Information
YJ9069 is a potent, selective and orally bioavailable PROTAC degrader of CDK12/CDK13. It inhibits proliferation in prostate cancer cells by inducing gene-length-dependent transcriptional elongation defects, leading to DNA damage, cell-cycle arrest, and significant tumor growth suppression in vivo.
More Discoveries
Explore Other Products
Browse additional items from our catalog
021-24 500 µg
Dynorphin A (2-13) amide (Human, Rat, Mouse, Porcine)
Sign In for Pricing
View Details A06709-1-Cy3 100 µg/Vial
Anti-RFX2 Antibody Picoband® Cy3 Conjugated
Sign In for Pricing
View Details 
K2418905 3x 1.0 µg
TNKS2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 